Karyopharm Therapeutics | KPTI - Stock


Karyopharm Therapeutics reported $3.97M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Abbott USD 6.49B 220M Dec/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
J&J USD 14.19B 45M Dec/2025
Karyopharm Therapeutics USD 3.97M 1.03M Sep/2025
MacroGenics USD 7.91M 840K Dec/2025
Merck USD 6.44B 157M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Takeda JPY 1.41T 107.71B Dec/2025
TG Therapeutics USD 125.59M 21.37M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025